Cover Image
市場調查報告書

生物性骨材市場預測EU5個國家

EU5 Orthobiologics Market Outlook to 2021

出版商 GlobalData 商品編碼 297563
出版日期 內容資訊 英文 261 Pages
訂單完成後即時交付
價格
Back to Top
生物性骨材市場預測EU5個國家 EU5 Orthobiologics Market Outlook to 2021
出版日期: 2015年10月01日 內容資訊: 英文 261 Pages
簡介

本報告提供EU5個國家生物性骨材市場相關調查分析,包含主要的市場資料(收益,數量,平均價格,企業佔有率,流通佔有率),主要企業簡介等,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 生物性骨材市場EU5個國家

  • 收益
  • 類別比較:各收益
  • 收益(實際成果)
  • 收益(預測)
  • 數量(實際成果)
  • 數量(預測)
  • 企業佔有率:各收益

第4章 法國的生物性骨材市場

  • 收益(實際成果)
  • 收益(預測)
  • 數量(實際成果)
  • 數量(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第5章 德國的生物性骨材市場

  • 收益(實際成果)
  • 收益(預測)
  • 數量(實際成果)
  • 數量(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第6章 義大利的生物性骨材市場

  • 收益(實際成果)
  • 收益(預測)
  • 數量(實際成果)
  • 數量(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第7章 西班牙的生物性骨材市場

  • 收益(實際成果)
  • 收益(預測)
  • 數量(實際成果)
  • 數量(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第8章 英國的生物性骨材市場

  • 收益(實際成果)
  • 收益(預測)
  • 數量(實際成果)
  • 數量(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第9章 EU5個國家生物性骨材市場上主要企業概要

  • DePuy Companies
  • Medtronic, Inc.
  • Sanofi
  • Biomet, Inc.
  • Stryker Corporation
  • Baxter International Inc.
  • DJO Finance LLC
  • Orthofix International N.V.
  • Wright Medical Group, Inc.
  • Anika Therapeutics, Inc.
  • 生化學工業
  • Smith & Nephew Plc

第10章 生物性骨材市場開發中產品

第11章 財務交易形勢

  • 資產交易
  • 夥伴關係

第12章 最近的發展趨勢

  • 企業宣傳
  • 公佈財報
  • 政府·一般關注議題
  • 法律規章
  • 其他的重要的趨勢
  • 產品新聞

第13章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECR0289DB

GlobalData's new report, "EU5 Orthobiologics Market Outlook to 2021", provides key market data on the EU5 Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Bone Growth Stimulators and Viscosupplementation.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Orthobiologics market categories - Bone Graft and Substitutes, Bone Growth Stimulators and Viscosupplementation.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Orthobiologics market.
  • Global corporate-level profiles of key companies operating within the EU5 Orthobiologics market.
  • Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Orthobiologics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Orthobiologics Market, EU5

  • 3.1. Orthobiologics Market, EU5, Revenue ($m), 2007-2021
  • 3.2. Orthobiologics Market, EU5, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Orthobiologics Market, EU5, Revenue ($m), 2007-2014
  • 3.4. Orthobiologics Market, EU5, Revenue ($m), 2014-2021
  • 3.5. Orthobiologics Market, EU5, Volume (Units), 2007-2021
  • 3.6. Orthobiologics Market, EU5, Volume (Units), 2007-2014
  • 3.7. Orthobiologics Market, EU5, Volume (Units), 2014-2021
  • 3.8. Orthobiologics Market, EU5, Company Share by Revenue ($m), 2014

4. Orthobiologics Market, France

  • 4.1. Orthobiologics Market, France, Revenue ($m), 2007-2014
  • 4.2. Orthobiologics Market, France, Revenue ($m), 2014-2021
    • 4.2.1. Bone Grafts and Substitutes Market, France, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Bone Growth Stimulators Market, France, Revenue ($m), by Segment, 2007-2014
    • 4.2.3. Viscosupplementation Market, France, Revenue ($m), by Segment, 2007-2014
    • 4.2.4. Bone Grafts and Substitutes Market, France, Revenue ($m), by Segment, 2014-2021
    • 4.2.5. Bone Growth Stimulators Market, France, Revenue ($m), by Segment, 2014-2021
    • 4.2.6. Viscosupplementation Market, France, Revenue ($m), by Segment, 2014-2021
  • 4.3. Orthobiologics Market, France, Volume (Units), 2007-2014
  • 4.4. Orthobiologics Market, France, Volume (Units), 2014-2021
    • 4.4.1. Bone Grafts and Substitutes Market, France, Volume (Units), by Segment, 2007-2014
    • 4.4.2. Bone Growth Stimulators Market, France, Volume (Units), by Segment, 2007-2014
    • 4.4.3. Viscosupplementation Market, France, Volume (Units), by Segment, 2007-2014
    • 4.4.4. Bone Grafts and Substitutes Market, France, Volume (Units), by Segment, 2014-2021
    • 4.4.5. Bone Growth Stimulators Market, France, Volume (Units), by Segment, 2014-2021
    • 4.4.6. Viscosupplementation Market, France, Volume (Units), by Segment, 2014-2021
  • 4.5. Orthobiologics Market, France, Average Price ($), 2007-2021
  • 4.6. Orthobiologics Market, France, Distribution Share by Revenue ($m), 2013-2014
  • 4.7. Orthobiologics Market, France, Company Share by Revenue ($m), 2014

5. Orthobiologics Market, Germany

  • 5.1. Orthobiologics Market, Germany, Revenue ($m), 2007-2014
  • 5.2. Orthobiologics Market, Germany, Revenue ($m), 2014-2021
    • 5.2.1. Bone Grafts and Substitutes Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Bone Growth Stimulators Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 5.2.3. Viscosupplementation Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 5.2.4. Bone Grafts and Substitutes Market, Germany, Revenue ($m), by Segment, 2014-2021
    • 5.2.5. Bone Growth Stimulators Market, Germany, Revenue ($m), by Segment, 2014-2021
    • 5.2.6. Viscosupplementation Market, Germany, Revenue ($m), by Segment, 2014-2021
  • 5.3. Orthobiologics Market, Germany, Volume (Units), 2007-2014
  • 5.4. Orthobiologics Market, Germany, Volume (Units), 2014-2021
    • 5.4.1. Bone Grafts and Substitutes Market, Germany, Volume (Units), by Segment, 2007-2014
    • 5.4.2. Bone Growth Stimulators Market, Germany, Volume (Units), by Segment, 2007-2014
    • 5.4.3. Viscosupplementation Market, Germany, Volume (Units), by Segment, 2007-2014
    • 5.4.4. Bone Grafts and Substitutes Market, Germany, Volume (Units), by Segment, 2014-2021
    • 5.4.5. Bone Growth Stimulators Market, Germany, Volume (Units), by Segment, 2014-2021
    • 5.4.6. Viscosupplementation Market, Germany, Volume (Units), by Segment, 2014-2021
  • 5.5. Orthobiologics Market, Germany, Average Price ($), 2007-2021
  • 5.6. Orthobiologics Market, Germany, Distribution Share by Revenue ($m), 2013-2014
  • 5.7. Orthobiologics Market, Germany, Company Share by Revenue ($m), 2014

6. Orthobiologics Market, Italy

  • 6.1. Orthobiologics Market, Italy, Revenue ($m), 2007-2014
  • 6.2. Orthobiologics Market, Italy, Revenue ($m), 2014-2021
    • 6.2.1. Bone Grafts and Substitutes Market, Italy, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Bone Growth Stimulators Market, Italy, Revenue ($m), by Segment, 2007-2014
    • 6.2.3. Viscosupplementation Market, Italy, Revenue ($m), by Segment, 2007-2014
    • 6.2.4. Bone Grafts and Substitutes Market, Italy, Revenue ($m), by Segment, 2014-2021
    • 6.2.5. Bone Growth Stimulators Market, Italy, Revenue ($m), by Segment, 2014-2021
    • 6.2.6. Viscosupplementation Market, Italy, Revenue ($m), by Segment, 2014-2021
  • 6.3. Orthobiologics Market, Italy, Volume (Units), 2007-2014
  • 6.4. Orthobiologics Market, Italy, Volume (Units), 2014-2021
    • 6.4.1. Bone Grafts and Substitutes Market, Italy, Volume (Units), by Segment, 2007-2014
    • 6.4.2. Bone Growth Stimulators Market, Italy, Volume (Units), by Segment, 2007-2014
    • 6.4.3. Viscosupplementation Market, Italy, Volume (Units), by Segment, 2007-2014
    • 6.4.4. Bone Grafts and Substitutes Market, Italy, Volume (Units), by Segment, 2014-2021
    • 6.4.5. Bone Growth Stimulators Market, Italy, Volume (Units), by Segment, 2014-2021
    • 6.4.6. Viscosupplementation Market, Italy, Volume (Units), by Segment, 2014-2021
  • 6.5. Orthobiologics Market, Italy, Average Price ($), 2007-2021
  • 6.6. Orthobiologics Market, Italy, Distribution Share by Revenue ($m), 2013-2014
  • 6.7. Orthobiologics Market, Italy, Company Share by Revenue ($m), 2014

7. Orthobiologics Market, Spain

  • 7.1. Orthobiologics Market, Spain, Revenue ($m), 2007-2014
  • 7.2. Orthobiologics Market, Spain, Revenue ($m), 2014-2021
    • 7.2.1. Bone Grafts and Substitutes Market, Spain, Revenue ($m), by Segment, 2007-2014
    • 7.2.2. Bone Growth Stimulators Market, Spain, Revenue ($m), by Segment, 2007-2014
    • 7.2.3. Viscosupplementation Market, Spain, Revenue ($m), by Segment, 2007-2014
    • 7.2.4. Bone Grafts and Substitutes Market, Spain, Revenue ($m), by Segment, 2014-2021
    • 7.2.5. Bone Growth Stimulators Market, Spain, Revenue ($m), by Segment, 2014-2021
    • 7.2.6. Viscosupplementation Market, Spain, Revenue ($m), by Segment, 2014-2021
  • 7.3. Orthobiologics Market, Spain, Volume (Units), 2007-2014
  • 7.4. Orthobiologics Market, Spain, Volume (Units), 2014-2021
    • 7.4.1. Bone Grafts and Substitutes Market, Spain, Volume (Units), by Segment, 2007-2014
    • 7.4.2. Bone Growth Stimulators Market, Spain, Volume (Units), by Segment, 2007-2014
    • 7.4.3. Viscosupplementation Market, Spain, Volume (Units), by Segment, 2007-2014
    • 7.4.4. Bone Grafts and Substitutes Market, Spain, Volume (Units), by Segment, 2014-2021
    • 7.4.5. Bone Growth Stimulators Market, Spain, Volume (Units), by Segment, 2014-2021
    • 7.4.6. Viscosupplementation Market, Spain, Volume (Units), by Segment, 2014-2021
  • 7.5. Orthobiologics Market, Spain, Average Price ($), 2007-2021
  • 7.6. Orthobiologics Market, Spain, Distribution Share by Revenue ($m), 2013-2014
  • 7.7. Orthobiologics Market, Spain, Company Share by Revenue ($m), 2014

8. Orthobiologics Market, United Kingdom

  • 8.1. Orthobiologics Market, United Kingdom, Revenue ($m), 2007-2014
  • 8.2. Orthobiologics Market, United Kingdom, Revenue ($m), 2014-2021
    • 8.2.1. Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 8.2.2. Bone Growth Stimulators Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 8.2.3. Viscosupplementation Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 8.2.4. Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
    • 8.2.5. Bone Growth Stimulators Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
    • 8.2.6. Viscosupplementation Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
  • 8.3. Orthobiologics Market, United Kingdom, Volume (Units), 2007-2014
  • 8.4. Orthobiologics Market, United Kingdom, Volume (Units), 2014-2021
    • 8.4.1. Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), by Segment, 2007-2014
    • 8.4.2. Bone Growth Stimulators Market, United Kingdom, Volume (Units), by Segment, 2007-2014
    • 8.4.3. Viscosupplementation Market, United Kingdom, Volume (Units), by Segment, 2007-2014
    • 8.4.4. Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), by Segment, 2014-2021
    • 8.4.5. Bone Growth Stimulators Market, United Kingdom, Volume (Units), by Segment, 2014-2021
    • 8.4.6. Viscosupplementation Market, United Kingdom, Volume (Units), by Segment, 2014-2021
  • 8.5. Orthobiologics Market, United Kingdom, Average Price ($), 2007-2021
  • 8.6. Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014
  • 8.7. Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2014

9. Overview of Key Companies in EU5 Orthobiologics Market

  • 9.1. Medtronic plc
    • 9.1.1. Company Overview
  • 9.2. DePuy Companies
    • 9.2.1. Company Overview
  • 9.3. Baxter International Inc.
    • 9.3.1. Company Overview
  • 9.4. Sanofi
    • 9.4.1. Company Overview
  • 9.5. Bioventus LLC
    • 9.5.1. Company Overview
  • 9.6. DJO Finance LLC
    • 9.6.1. Company Overview
  • 9.7. Arthrex, Inc.
    • 9.7.1. Company Overview
  • 9.8. Anika Therapeutics, Inc.
    • 9.8.1. Company Overview
  • 9.9. Seikagaku Corporation
    • 9.9.1. Company Overview
  • 9.10. Biomet, Inc. (Inactive)
    • 9.10.1. Company Overview
  • 9.11. Rottapharm Madaus GmbH
    • 9.11.1. Company Overview
  • 9.12. Stryker Corporation
    • 9.12.1. Company Overview
  • 9.13. Ossatec Benelux B.V.
    • 9.13.1. Company Overview

10. Orthobiologics Market Pipeline Products

11. Recent Developments

  • 11.1. Corporate Communications
    • 11.1.1. Aug 27, 2015: ESC Congress 2015: BIOTRONIK Announces CE Approval and Pilot Study Results for BioMonitor 2
    • 11.1.2. Jul 31, 2015: TiGenix: Dirk Buscher and Jose Terencio resign from TiGenix board of directors
    • 11.1.3. Jun 25, 2015: GenomeDx's Decipher Prostate Cancer Classifier Accurately Predicts Metastasis Ten Years after Prostate Removal in Study Published by European Urology
  • 11.2. Financial Announcements
    • 11.2.1. Oct 19, 2015: DelMar Pharmaceuticals Presents Positive Preclinical Data on VAL-083 as a Promising Treatment for Ovarian Cancer
    • 11.2.2. Sep 15, 2015: TiGenix Business and Financial Update for the First Half of 2015
    • 11.2.3. Sep 03, 2015: Medtronic Reports First Quarter Financial Results
    • 11.2.4. Aug 25, 2015: Entellus Medical Surpasses 100,000 Patients Treated Worldwide
    • 11.2.5. Aug 22, 2015: HealthSpot disrupts the lab industry with plans to bring 7 minute blood tests to retail pharmacy clinics
    • 11.2.6. Jun 25, 2015: Ventripoint Announces Development of New VMS Products and Enhanced Capabilities as Featured at ASE 2015
    • 11.2.7. Mar 17, 2015: TiGenix reports its full year 2014. results
    • 11.2.8. Feb 17, 2015: Medtronic Reports Third Quarter Earnings
    • 11.2.9. Feb 13, 2015: Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2015
  • 11.3. Government and Public Interest
    • 11.3.1. Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean
  • 11.4. Legal And Regulatory
    • 11.4.1. Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79
  • 11.5. Other Significant Developments
    • 11.5.1. Nov 05, 2015: Medtronic Releases 2015 Integrated Performance Report
    • 11.5.2. Nov 04, 2015: Wright Medical Group Reports 2015 Third Quarter Financial Results
  • 11.6. Strategy And Business Planning
    • 11.6.1. Jun 25, 2015: The Only Permanent, FDA-Cleared, Non-Invasive Solution to Underarm Sweat, Now Available at Boston Plastic Surgery
    • 11.6.2. Jun 24, 2015: LifeVac Registered With UK Ministry of Health

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Market Modeling and Forecasting
    • 12.1.5. Company Share Analysis
    • 12.1.6. Distribution Share Analysis
  • 12.2. Expert Panel
  • 12.3. GlobalData Consulting
  • 12.4. Contact Us
  • 12.5. Disclaimer

List of Tables

  • Table 1: Orthobiologics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Orthobiologics Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Orthobiologics Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Orthobiologics Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Orthobiologics Market, EU5, Volume (Units), 2007-2021
  • Table 6: Orthobiologics Market, EU5, Volume (Units), Historic, 2007-2014
  • Table 7: Orthobiologics Market, EU5, Volume (Units), Forecast, 2014-2021
  • Table 8: Orthobiologics Market, EU5, Company Share by Revenue ($m), USD Constant, 2014
  • Table 9: Orthobiologics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 10: Orthobiologics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 11: Bone Grafts and Substitutes Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Bone Growth Stimulators Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Viscosupplementation Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 14: Bone Grafts and Substitutes Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 15: Bone Growth Stimulators Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Viscosupplementation Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 17: Orthobiologics Market, France, Volume (Units), Historic, 2007-2014
  • Table 18: Orthobiologics Market, France, Volume (Units), Forecast, 2014-2021
  • Table 19: Bone Grafts and Substitutes Market, France, Volume (Units), Historic, 2007-2014
  • Table 20: Bone Growth Stimulators Market, France, Volume (Units), Historic, 2007-2014
  • Table 21: Viscosupplementation Market, France, Volume (Units), Historic, 2007-2014
  • Table 22: Bone Grafts and Substitutes Market, France, Volume (Units), Forecast, 2014-2021
  • Table 23: Bone Growth Stimulators Market, France, Volume (Units), Forecast, 2014-2021
  • Table 24: Viscosupplementation Market, France, Volume (Units), Forecast, 2014-2021
  • Table 25: Orthobiologics Market, France, Average Price ($) Historic, 2007-2014
  • Table 26: Orthobiologics Market, France, Average Price ($), Forecast, 2014-2021
  • Table 27: Orthobiologics Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 28: Orthobiologics Market, France, Company Share by Revenue ($m), USD Constant, 2014
  • Table 29: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 30: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 31: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 32: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 33: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 34: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 35: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 36: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 37: Orthobiologics Market, Germany, Volume (Units), Historic, 2007-2014
  • Table 38: Orthobiologics Market, Germany, Volume (Units), Forecast, 2014-2021
  • Table 39: Bone Grafts and Substitutes Market, Germany, Volume (Units), Historic, 2007-2014
  • Table 40: Bone Growth Stimulators Market, Germany, Volume (Units), Historic, 2007-2014
  • Table 41: Viscosupplementation Market, Germany, Volume (Units), Historic, 2007-2014
  • Table 42: Bone Grafts and Substitutes Market, Germany, Volume (Units), Forecast, 2014-2021
  • Table 43: Bone Growth Stimulators Market, Germany, Volume (Units), Forecast, 2014-2021
  • Table 44: Viscosupplementation Market, Germany, Volume (Units), Forecast, 2014-2021
  • Table 45: Orthobiologics Market, Germany, Average Price ($) Historic, 2007-2014
  • Table 46: Orthobiologics Market, Germany, Average Price ($), Forecast, 2014-2021
  • Table 47: Orthobiologics Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 48: Orthobiologics Market, Germany, Company Share by Revenue ($m), USD Constant, 2014
  • Table 49: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 50: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 51: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 52: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 53: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 54: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 55: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 56: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 57: Orthobiologics Market, Italy, Volume (Units), Historic, 2007-2014
  • Table 58: Orthobiologics Market, Italy, Volume (Units), Forecast, 2014-2021
  • Table 59: Bone Grafts and Substitutes Market, Italy, Volume (Units), Historic, 2007-2014
  • Table 60: Bone Growth Stimulators Market, Italy, Volume (Units), Historic, 2007-2014
  • Table 61: Viscosupplementation Market, Italy, Volume (Units), Historic, 2007-2014
  • Table 62: Bone Grafts and Substitutes Market, Italy, Volume (Units), Forecast, 2014-2021
  • Table 63: Bone Growth Stimulators Market, Italy, Volume (Units), Forecast, 2014-2021
  • Table 64: Viscosupplementation Market, Italy, Volume (Units), Forecast, 2014-2021
  • Table 65: Orthobiologics Market, Italy, Average Price ($) Historic, 2007-2014
  • Table 66: Orthobiologics Market, Italy, Average Price ($), Forecast, 2014-2021
  • Table 67: Orthobiologics Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 68: Orthobiologics Market, Italy, Company Share by Revenue ($m), USD Constant, 2014
  • Table 69: Orthobiologics Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 70: Orthobiologics Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 71: Bone Grafts and Substitutes Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 72: Bone Growth Stimulators Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 73: Viscosupplementation Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 74: Bone Grafts and Substitutes Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 75: Bone Growth Stimulators Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 76: Viscosupplementation Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 77: Orthobiologics Market, Spain, Volume (Units), Historic, 2007-2014
  • Table 78: Orthobiologics Market, Spain, Volume (Units), Forecast, 2014-2021
  • Table 79: Bone Grafts and Substitutes Market, Spain, Volume (Units), Historic, 2007-2014
  • Table 80: Bone Growth Stimulators Market, Spain, Volume (Units), Historic, 2007-2014
  • Table 81: Viscosupplementation Market, Spain, Volume (Units), Historic, 2007-2014
  • Table 82: Bone Grafts and Substitutes Market, Spain, Volume (Units), Forecast, 2014-2021
  • Table 83: Bone Growth Stimulators Market, Spain, Volume (Units), Forecast, 2014-2021
  • Table 84: Viscosupplementation Market, Spain, Volume (Units), Forecast, 2014-2021
  • Table 85: Orthobiologics Market, Spain, Average Price ($) Historic, 2007-2014
  • Table 86: Orthobiologics Market, Spain, Average Price ($), Forecast, 2014-2021
  • Table 87: Orthobiologics Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 88: Orthobiologics Market, Spain, Company Share by Revenue ($m), USD Constant, 2014
  • Table 89: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 90: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 91: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 92: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 93: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 94: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 95: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 96: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 97: Orthobiologics Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Table 98: Orthobiologics Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Table 99: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Table 100: Bone Growth Stimulators Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Table 101: Viscosupplementation Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Table 102: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Table 103: Bone Growth Stimulators Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Table 104: Viscosupplementation Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Table 105: Orthobiologics Market, United Kingdom, Average Price ($) Historic, 2007-2014
  • Table 106: Orthobiologics Market, United Kingdom, Average Price ($), Forecast, 2014-2021
  • Table 107: Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 108: Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014
  • Table 109: Orthobiologics Market Pipeline Products
  • Table 110: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Orthobiologics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Orthobiologics Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Orthobiologics Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Orthobiologics Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Orthobiologics Market, EU5, Volume (Units), 2007-2021
  • Figure 6: Orthobiologics Market, EU5, Volume (Units), Historic, 2007-2014
  • Figure 7: Orthobiologics Market, EU5, Volume (Units), Forecast, 2014-2021
  • Figure 8: Orthobiologics Market, EU5, Company Share (%) 2014
  • Figure 9: Orthobiologics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 10: Orthobiologics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 11: Bone Grafts and Substitutes Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Bone Growth Stimulators Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 13: Viscosupplementation Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 14: Bone Grafts and Substitutes Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 15: Bone Growth Stimulators Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 16: Viscosupplementation Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 17: Orthobiologics Market, France, Volume (Units), Historic, 2007-2014
  • Figure 18: Orthobiologics Market, France, Volume (Units), Forecast, 2014-2021
  • Figure 19: Bone Grafts and Substitutes Market, France, Volume (Units), Historic, 2007-2014
  • Figure 20: Bone Growth Stimulators Market, France, Volume (Units), Historic, 2007-2014
  • Figure 21: Viscosupplementation Market, France, Volume (Units), Historic, 2007-2014
  • Figure 22: Bone Grafts and Substitutes Market, France, Volume (Units), Forecast, 2014-2021
  • Figure 23: Bone Growth Stimulators Market, France, Volume (Units), Forecast, 2014-2021
  • Figure 24: Viscosupplementation Market, France, Volume (Units), Forecast, 2014-2021
  • Figure 25: Orthobiologics Market, France, Company Share (%) 2014
  • Figure 26: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 27: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 28: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 29: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 30: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 31: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 32: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 33: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 34: Orthobiologics Market, Germany, Volume (Units), Historic, 2007-2014
  • Figure 35: Orthobiologics Market, Germany, Volume (Units), Forecast, 2014-2021
  • Figure 36: Bone Grafts and Substitutes Market, Germany, Volume (Units), Historic, 2007-2014
  • Figure 37: Bone Growth Stimulators Market, Germany, Volume (Units), Historic, 2007-2014
  • Figure 38: Viscosupplementation Market, Germany, Volume (Units), Historic, 2007-2014
  • Figure 39: Bone Grafts and Substitutes Market, Germany, Volume (Units), Forecast, 2014-2021
  • Figure 40: Bone Growth Stimulators Market, Germany, Volume (Units), Forecast, 2014-2021
  • Figure 41: Viscosupplementation Market, Germany, Volume (Units), Forecast, 2014-2021
  • Figure 42: Orthobiologics Market, Germany, Company Share (%) 2014
  • Figure 43: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 44: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 45: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 46: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 47: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 48: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 49: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 50: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 51: Orthobiologics Market, Italy, Volume (Units), Historic, 2007-2014
  • Figure 52: Orthobiologics Market, Italy, Volume (Units), Forecast, 2014-2021
  • Figure 53: Bone Grafts and Substitutes Market, Italy, Volume (Units), Historic, 2007-2014
  • Figure 54: Bone Growth Stimulators Market, Italy, Volume (Units), Historic, 2007-2014
  • Figure 55: Viscosupplementation Market, Italy, Volume (Units), Historic, 2007-2014
  • Figure 56: Bone Grafts and Substitutes Market, Italy, Volume (Units), Forecast, 2014-2021
  • Figure 57: Bone Growth Stimulators Market, Italy, Volume (Units), Forecast, 2014-2021
  • Figure 58: Viscosupplementation Market, Italy, Volume (Units), Forecast, 2014-2021
  • Figure 59: Orthobiologics Market, Italy, Company Share (%) 2014
  • Figure 60: Orthobiologics Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 61: Orthobiologics Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 62: Bone Grafts and Substitutes Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 63: Bone Growth Stimulators Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 64: Viscosupplementation Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 65: Bone Grafts and Substitutes Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 66: Bone Growth Stimulators Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 67: Viscosupplementation Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 68: Orthobiologics Market, Spain, Volume (Units), Historic, 2007-2014
  • Figure 69: Orthobiologics Market, Spain, Volume (Units), Forecast, 2014-2021
  • Figure 70: Bone Grafts and Substitutes Market, Spain, Volume (Units), Historic, 2007-2014
  • Figure 71: Bone Growth Stimulators Market, Spain, Volume (Units), Historic, 2007-2014
  • Figure 72: Viscosupplementation Market, Spain, Volume (Units), Historic, 2007-2014
  • Figure 73: Bone Grafts and Substitutes Market, Spain, Volume (Units), Forecast, 2014-2021
  • Figure 74: Bone Growth Stimulators Market, Spain, Volume (Units), Forecast, 2014-2021
  • Figure 75: Viscosupplementation Market, Spain, Volume (Units), Forecast, 2014-2021
  • Figure 76: Orthobiologics Market, Spain, Company Share (%) 2014
  • Figure 77: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 78: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 79: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 80: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 81: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 82: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 83: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 84: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 85: Orthobiologics Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Figure 86: Orthobiologics Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Figure 87: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Figure 88: Bone Growth Stimulators Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Figure 89: Viscosupplementation Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Figure 90: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Figure 91: Bone Growth Stimulators Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Figure 92: Viscosupplementation Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Figure 93: Orthobiologics Market, United Kingdom, Company Share (%) 2014
  • Figure 94: GlobalData Epidemiology-Based Forecasting Model
  • Figure 95: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 96: Primary Interviews by Participant Type (%)
Back to Top